Journal
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
Volume 121, Issue -, Pages 51-59Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.yjmcc.2018.06.002
Keywords
Phospholipase C; Cardiac hypertrophy; Phosphatidylinositol 4-phosphate; Phosphodiesterase; Epac; Cyclic AMP; A kinase anchoring protein; Golgi apparatus
Categories
Funding
- U.S. National Institutes of Health (NIH) [R01GM0535336]
- NIH [T32-HL007853]
Ask authors/readers for more resources
In cardiac myocytes activation of an exchange factor activated by cAMP (Epac) leads to activation of phospholipase C epsilon (PLC epsilon)-dependent hydrolysis of phosphatidylinositol 4-phosphate (PI4P) in the Golgi apparatus a process critical for development of cardiac hypertrophy. Here we show that beta-adrenergic receptor (beta AR) stimulation does not stimulate this pathway in the presence of the broad spectrum phosphodiesterase (PDE) inhibitor IBMX, but selective PDE3 inhibition revealed beta AR-dependent PI4P depletion. On the other hand, selective inhibition of PDE2 or PDE9A blocked endothelin-1 (ET-1) and cAMP-dependent PI4P hydrolysis by PLC epsilon. Direct activation of protein kinase A (PKA), protein kinase G (PKG), or the atrial natriuretic factor (ANF) receptor abolished PI4P hydrolysis in response to multiple upstream stimuli. These results reveal distinct pools of cyclic nucleotides that either inhibit PLCe at the Golgi through PKA/PKG, or activate PLC epsilon at the Golgi through Epac. These data together reveal a new mechanism by which ANF and selective PDE inhibitors can protect against cardiac hypertrophy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available